Article
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector Platform.
Molecular therapy : the journal of the American Society of Gene Therapy - 1 Aug 2016
Hübner Juwita, Hoseini Shahabuddin S, Suerth Julia D, Hoffmann Dirk, Maluski Marcel, Herbst Jessica, Maul Holger, Ghosh Arnab, Eiz-Vesper Britta, Yuan Qinggong, Ott Michael, Heuser Michael, Schambach Axel, Sauer Martin G
Abstract excerpt
Retroviral engineering of hematopoietic stem cell-derived precursor T-cells (preTs) opens the possibility of targeted T-cell transfer across human leukocyte antigen (HLA)-barriers. Alpharetroviral vectors exhibit a more neutral integration pattern thereby reducing the risk of insertional mutagenesis. Cord blood-derived CD34+ cells were transduced and differentiated into preTs in vitro. Two promoters,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
